Pathogenesis and classification of primary central nervous system lymphoma: an update (Q41282386)

29 September 2017

1 reference

title

Pathogenesis and classification of primary central nervous system lymphoma: an update (English)

1 reference

central nervous system lymphoma

29 September 2017

0 references

1 reference

based on heuristic

inferred from title

primary central nervous system lymphoma

1 reference

Morgello S

1 reference

29 September 2017

publication date

1 October 1995

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

page(s)

383-393

1 reference

Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyme

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Immunophenotypic profile of CNS lymphoma: a review of eighteen cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Detection of Epstein-Barr virus sequences in primary brain lymphoma without immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

The capacity of human malignant B-lymphocytes to disseminate in SCID mice is correlated with functional expression of the fibronectin receptor alpha 5 beta 1 (CD49e/CD29).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Increasing incidence of primary brain lymphoma in the US

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary Central Nervous System Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Molecular basis of latency in pathogenic human viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary central nervous system lymphomas--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Viral latency and transformation: the strategy of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Diagnosis of Epstein-Barr virus-induced central nervous system infections by DNA amplification from cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

The switch between latency and replication of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

In situ hybridization for the detection of Epstein-Barr virus in central nervous system lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Comparison of integrin adhesion molecules expressed by primary brain lymphomas and nodal lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Human herpesvirus-6 and Epstein-Barr virus genome in primary cerebral lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Detection of Epstein-Barr virus in the brain by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary central nervous system lymphoma related to Epstein-Barr virus in a patient with acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary central nervous system lymphomas in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Demonstration of Epstein-Barr virus in primary central nervous system lymphomas by the polymerase chain reaction and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Jumping genes and the immunoglobulin V gene system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

An intricate route to immortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

Geographical prevalence of two types of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1995.TB00616.X

10.1111/J.1750-3639.1995.TB00616.X

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference